StockNews.com started coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research note released on Wednesday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Piper Sandler reiterated a neutral rating on shares of Infinity Pharmaceuticals in a research report on Friday, February 24th. Infinity Pharmaceuticals Trading Down 3.3 […]